<PubmedArticle>
<MedlineCitation IndexingMethod="Curated" Owner="NLM" Status="MEDLINE">
<PMID Version="1">25721698</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>03</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>12</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-4111</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>80</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Maturitas</Title>
<ISOAbbreviation>Maturitas</ISOAbbreviation>
</Journal>
<ArticleTitle>Estimation of the optimum dose of vitamin D for disease prevention in older people: rationale, design and baseline characteristics of the BEST-D trial.</ArticleTitle>
<Pagination>
<MedlinePgn>426-31</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.maturitas.2015.01.013</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0378-5122(15)00030-4</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Previous large trials of vitamin D for prevention of fractures and other disease outcomes have reported conflicting results, possibly because the doses tested were insufficient to maintain optimum blood levels of vitamin D (25[OH]D) predicted by the observational studies. This report describes the design and baseline characteristics of the BEST-D (Biochemical Efficacy and Safety Trial of vitamin D) trial which aims to establish the best dose of vitamin D to assess in a future large outcome trial.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The BEST-D trial will compare the biochemical and other effects of daily dietary supplementation with 100 μg or 50 μg vitamin D3 or placebo, when administered for 12 months, in 305 ambulant community-dwelling older people living in Oxfordshire, England. The primary analyses will compare 12-month mean plasma concentrations of 25(OH)D as well as the proportion of participants with a 12-month concentration &gt;90 nmol/L between participants allocated 100 μg and participants allocated 50 μg daily. Secondary analyses will compare the two active doses (both separately and when combined) with placebo. Additional end-points include biochemical assessments of safety, blood pressure, arterial stiffness, falls, fractures, heel and wrist bone density, grip strength and physical performance and echocardiographic assessments of cardiac function in a random sample of participants.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">About one-third of eligible participants agreed to participate in the trial. The mean age was 72 (SD 6) years with equal numbers of men and women. About one third reported a prior history of fracture or hypertension, one-fifth reported a prior cardiovascular event, and one tenth reported diabetes or a fall in the previous 6 months.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results of this trial will help determine the optimum dose of vitamin D to test in a larger trial investigating whether vitamin D supplementation can reduce the risk of fractures, cardiovascular disease or cancer.</AbstractText>
<CopyrightInformation>Crown Copyright © 2015. Published by Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Clarke</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK. Electronic address: Robert.clarke@ctsu.ox.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Newman</LastName>
<ForeName>Connie</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Endocrinology &amp; Metabolism, New York University School of Medicine, New York, NY, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tomson</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hin</LastName>
<ForeName>Harold</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Hightown Surgery, Banbury, Oxfordshire, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Kurien</LastName>
<ForeName>Rijo</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cox</LastName>
<ForeName>Jolyon</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lay</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Sayer</LastName>
<ForeName>Jenny</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hill</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Emberson</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Armitage</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>EudraCT</DataBankName>
<AccessionNumberList>
<AccessionNumber>2011-005763-24</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>PG/12/32/29544</GrantID>
<Agency>British Heart Foundation</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_U137686861</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<Agency>Cancer Research UK</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_U137686853</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>MC_U137686855</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>02</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Ireland</Country>
<MedlineTA>Maturitas</MedlineTA>
<NlmUniqueID>7807333</NlmUniqueID>
<ISSNLinking>0378-5122</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D050071">Bone Density Conservation Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1406-16-2</RegistryNumber>
<NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>1C6V77QF41</RegistryNumber>
<NameOfSubstance UI="D002762">Cholecalciferol</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>A288AR3C9H</RegistryNumber>
<NameOfSubstance UI="C104450">25-hydroxyvitamin D</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000058">Accidental Falls</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015519">Bone Density</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050071">Bone Density Conservation Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002762">Cholecalciferol</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000008">administration &amp; dosage</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019587">Dietary Supplements</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004452">Echocardiography</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050723">Fractures, Bone</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000517">prevention &amp; control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018737">Hand Strength</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006321">Heart</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012107">Research Design</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D059289">Vascular Stiffness</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D014807">Vitamin D</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000031">analogs &amp; derivatives</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">07034656</Keyword>
<Keyword MajorTopicYN="N">25-Hydroxyvitamin D</Keyword>
<Keyword MajorTopicYN="N">EudraCT number: 2011-005763-24</Keyword>
<Keyword MajorTopicYN="N">Parathyroid hormone</Keyword>
<Keyword MajorTopicYN="N">Vitamin D supplementation trial</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>11</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2015</Year>
<Month>01</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>01</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>2</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>2</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>3</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">25721698</ArticleId>
<ArticleId IdType="pii">S0378-5122(15)00030-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.maturitas.2015.01.013</ArticleId>
<ArticleId IdType="pmc">PMC4387549</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Br J Cancer. 1977 Jan;35(1):1-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">831755</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Age Ageing. 2005 Sep;34(5):485-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16043444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2005 May 7-13;365(9471):1621-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15885294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1992 Dec 3;327(23):1637-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1331788</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 1996 Feb 15;124(4):400-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8554248</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1998 Mar 19;338(12):777-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9504937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2004 Dec;80(6 Suppl):1706S-9S</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15585791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Psychogeriatr. 1991 Spring;3(1):23-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1863703</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Osteoporos Int. 2005 Nov;16(11):1425-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15744449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2006 Feb 16;354(7):669-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16481635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2006 Jul;84(1):18-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16825677</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Jul 19;357(3):266-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17634462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Epidemiol. 2007 Dec 1;166(11):1327-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17716981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18088161</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Bone Miner Res. 2008 Jan;23(1):143-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17907920</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Age Ageing. 2008 Sep;37(5):589-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18664518</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Intern Med. 2009 Mar 23;169(6):551-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19307517</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cochrane Database Syst Rev. 2009;(2):CD000227</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19370554</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2010;340:b5463</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20068257</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2010 Mar 30;55(13):1318-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20338492</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2011 Apr 14;364(15):1385-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21428761</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Age Ageing. 2011 Jul;40(4):423-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21624928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2012 Jul 5;367(1):40-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22762317</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2012 Sep 21;337(6101):1476-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22997323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 2013 May;34(18):1365-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23257953</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2014;348:g1903</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24690623</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Nutr. 1999 Jul;82(1):7-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10655951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2003 Jan;77(1):204-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12499343</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2003 Mar 1;326(7387):469</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12609940</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Cancer. 1976 Dec;34(6):585-612</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">795448</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>